Metal Tycoon to Leapfrog Elon Musk With World's Biggest Battery
(Bloomberg) -- Sanjeev Gupta plans to snatch the world's biggest battery crown from Tesla Inc. founder Elon Musk.
Simec Zen Energy, controlled by the U.K. executive's GFG Alliance, agreed to build a 120-megawatt lithium-ion battery at Port Augusta in South Australia, State Premier Jay Weatherill said in an emailed statement Friday. While no timeline was given for completion, the battery size would exceed Musk's 100-megawatt unit in the same state's outback, which holds the current record. Other rivals may also overtake Musk including a South Korean project.
GFG, which last year added steel operations to iron ore mines in Australia, said the battery will help power a 200 megawatt solar farm at its Whyalla steelworks. Simec Zen hopes its Big Battery Project will provide grid stability and act as a buffer to power outages, which have included a state-wide blackout in September 2016.
“As well as being the most powerful battery in the world, Simec Zen's storage facility will help underpin the long-term viability of the Whyalla steelworks as well as provide additional benefits to the South Australian grid,” Weatherill said.
The battery-storage industry is becoming increasingly important in places like South Australia, which has less access to traditional fossil-fuel sources like coal and gas than the rest of the nation. Instead, the region gets 50 percent of its electricity from renewable energy, one of the highest penetrations of wind and solar in the world.
To contact the reporter on this story: Perry Williams in Sydney at pwilliams113@bloomberg.net.
To contact the editors responsible for this story: Ramsey Al-Rikabi at ralrikabi@bloomberg.net, Aaron Clark, Alpana Sarma
©2018 Bloomberg L.P.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.